Probucol prevents lipid storage in macrophages

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Macrophage foam cell formation is a key process in atherosclerosis.
• Acetylated low-density lipoprotein (acetyl-LDL) is implicated in foam cell development.
• Probucol is a lipid-lowering drug with potential anti-atherosclerotic effects.

Purpose of the Study:

• To investigate the effect of probucol on lipid accumulation in macrophages.
• To determine if probucol inhibits foam cell formation in vitro.
• To correlate in vitro findings with clinical observations of probucol's efficacy.

Main Methods:

• Utilized macrophage-like UE-12 cells derived from U-937 cell line.
• Observed cellular morphology using light and electron microscopy.
• Quantified intracellular cholesterol levels via microscale enzymatic assay.
• Administered probucol in ethanolic solution or bound to LDL.

Main Results:

• Probucol significantly inhibited the transformation of macrophages into foam cells.
• Intracellular accumulation of esterified cholesterol induced by acetyl-LDL was markedly reduced by probucol.
• Probucol concentrations used were comparable to therapeutic plasma levels.
• Suggested probucol may interfere with acetyl-LDL binding to cell receptors.

Conclusions:

• Probucol demonstrates a potent inhibitory effect on macrophage foam cell formation in vitro.
• The drug's mechanism may involve preventing acetyl-LDL uptake.
• Findings align with clinical observations of probucol's effectiveness in xanthoma regression.